Skip to main content
Log in

Value of whole-body contrast-enhanced magnetic resonance angiography with vessel wall imaging in quantitative assessment of disease activity and follow-up examination in Takayasu’s arteritis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

The aim of this study is to determine the value of whole-body contrast-enhanced magnetic resonance angiography(CE-MRI) with vessel wall imaging in quantitative assessments of Takayasu’s arteritis (TA) disease activity and follow-up examinations. Whole-body CE-MRI with vessel wall imaging (dark blood sequences) was performed in 52 TA patients and repeated in 15 patients after 6 months. Images were analyzed using quantitative scores. The distribution of Lupi-Herrera types (type III, 48.1 %; I, 40.4 %; II, 9.6 %; IV, 1.9 %) did not differ between active and inactive TA. Active vessel inflammation was found in seven patients diagnosed with inactive disease as Kerr scores and mainly involved the aortic arch, abdominal aorta, and ascending aorta. Quantitative MR scores were significantly higher in active TA (luminal stenosis 16.7 ± 5.3 vs. 4.2 ± 3.7, p < 0.01; wall thickening 7.2 ± 3.4 vs. 2.9 ± 2.3, p = 0.02; wall enhancement 8.7 ± 4.1 vs. 3.6 ± 2.4, p = 0.04) and positively correlated with Kerr scores, ITAS 2010, erythrocyte-sedimentation rate (ESR), and C-reactive protein (CRP) and pentraxin-3 (PTX-3) levels. At 6 months, the clinical symptoms, CRP level, and ESR improved significantly (p < 0.05) and wall enhancement decreased (6.7 ± 3.1 vs. 4.1 ± 2.1; p = 0.04), but the luminal stenosis (10.2 ± 4.3 vs. 8.8 ± 5.2; p = 0.12) and wall thickening (6.3 ± 3.8 vs. 5.8 ± 4.2; p = 0.27) remained unchanged. Whole-body CE-MRI with vessel wall imaging detected luminal changes and vessel wall inflammation in TA. Our MR scoring system enabled quantitative assessment of TA activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Johnston SL, Lock RJ, Gompels MM (2002) Takayasu’s arteritis: a review. J Clin Pathol 55:481–486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Matsuura K, Ogino H, Kobayashi J et al (2005) Surgical treatment of aortic regurgitation due to Takayasu arteritis: long-term morbidity and mortality. Circulation 112:3707–3712

    Article  PubMed  Google Scholar 

  3. Kerr GS, Hallahan CW, Giordano J et al (1994) Takayasu arteritis. Ann Intern Med 120:919–929

    Article  CAS  PubMed  Google Scholar 

  4. Andrews J, Mason JC (2007) Takayasu’s arteritis—recent advances in imaging offer promise. Rheumatology (Oxford) 46:6–15

    Article  CAS  PubMed  Google Scholar 

  5. Chung JW, Kim HC, Choi YH et al (2007) Patterns of aortic involvement in Takayasu’s arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg 45:906–914

    Article  PubMed  Google Scholar 

  6. Giodrana P, Baqué-Juston MC, Jeandel PY et al (2011) Contrast-enhanced ultrasound of carotid artery wall in Takayasu’s disease: first evidence of application in diagnosis and monitoring response to treatment. Circulation 124:245–247

    Article  Google Scholar 

  7. Lee KH, Cho A, Choi YJ et al (2012) The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu’s arteritis. Arthritis Rheum 64:866–875

    Article  PubMed  Google Scholar 

  8. Wasserman BA, Astor BC, Sharrett AR et al (2010) MRI measurements of carotid plaque in the atherosclerosis risk in communities (ARIC) study: methods, reliability and descriptive statistics. J Magn Reson Imaging 31:406–415

    Article  PubMed  PubMed Central  Google Scholar 

  9. Laible M, Schoenberg SO, Weckbach S et al (2012) Whole-body MRI and MRA for evaluation of the prevalence of atherosclerosis in a cohort of subjectively healthy individuals. Insight Imaging 3:485–493

    Article  CAS  Google Scholar 

  10. Filer A, Nicholls D, Corston R et al (2001) Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage. J Rheumatol 28:2752–2753

    CAS  PubMed  Google Scholar 

  11. Ragab Y, Emad Y, El-Marakbi A et al (2007) Clinical utility of magnetic resonance angiography (MRA) in the diagnosis and treatment of Takayasu’s arteritis. Clin Rheumatol 26:1393–1395

    Article  PubMed  Google Scholar 

  12. Hansen T, Wikstrom J, Eriksson MO et al (2006) Whole-body magnetic resonance angiography of patients using a standard clinical scanner. Eur Radiol 16:147–153

    Article  PubMed  Google Scholar 

  13. Desai MY, Stone JH, Foo TK et al (2005) Delayed contrast-enhanced MRI of the aortic wall in Takayasu’s arteritis: initial experience. AJR 184:1427–1431

    Article  PubMed  Google Scholar 

  14. Lin J, Chen B, Wang JH et al (2006) Whole-body three-dimensional contrast-enhanced magnetic resonance (MR) angiography with parallel imaging techniques on a multichannel MR system for the detection of various systemic arterial diseases. Heart Vessels 21:395–398

    Article  PubMed  Google Scholar 

  15. Jiang L, Li D, Yan F et al (2012) Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging. Int J Cardiol 155:262–267

    Article  PubMed  Google Scholar 

  16. Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu’s arteritis. Arthritis Rheum 33:1129–1134

    Article  CAS  PubMed  Google Scholar 

  17. Lupi-Herrera E, Sanchez-Torres G, Marcushamer J et al (1977) Takayasu’s arteritis. Clinical study of 107 cases. Am Heart J 93:94–103

    Article  CAS  PubMed  Google Scholar 

  18. Misra R, Danada D, Rajapa SM et al (2013) Development and validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology (Oxford) 52:1795–1801

    Article  PubMed  Google Scholar 

  19. Sider L, Mintzer RA, Vrla RF et al (1985) Use of DSA for diagnosis of Takayasu’s arteritis. IMJ III Med J 167:53–55

    CAS  Google Scholar 

  20. Papa M, De Cobelli F, Baldissera E et al (2012) Takayasu’s arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity. AJR Am J Roentgenol 198:279–284

    Article  Google Scholar 

  21. Schneeweis C, Schnackenburg B, Stuber M et al (2012) Delayed contrast-enhanced MRI of the coronary artery wall in takayasu’s arteritis. PLoS One 7:e50655

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Sun Y, Ma L, Jiang L et al (2012) MMP-9 and IL-6 are potential biomarkers for disease activity in Takayasu’s arteritis. Int J Cardiol 156:236–238

    Article  PubMed  Google Scholar 

  23. Maekawa Y, Nagai T, Anzai A (2011) Pentraxins: CRP and PTX-3 and cardiovascular disease. Inflamm Allergy Drug Targets 10:229–235

    Article  CAS  PubMed  Google Scholar 

  24. Eshet Y, Pauzner R, Goitein O et al (2011) The limited role of MRI in long-term follow-up of patients with Takayasu’s arteritis. Autoimmun Rev 11:132–136

    Article  PubMed  Google Scholar 

Download references

Disclosure

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lindi Jiang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, Y., Ma, L., Ji, Z. et al. Value of whole-body contrast-enhanced magnetic resonance angiography with vessel wall imaging in quantitative assessment of disease activity and follow-up examination in Takayasu’s arteritis. Clin Rheumatol 35, 685–693 (2016). https://doi.org/10.1007/s10067-015-2885-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2885-2

Keywords

Navigation